Abstract:G-quadruplex structures are attractive targets for the development of anticancer drugs, as their formation in human telomere could impair telomerase activity, thus inducing apoptosis in cancer cells. In this work, a thiophene-containing dinuclear ruthenium(II) complex, [Ru-2(bpy)(4)(H(2)bipt)](4+) {bpy=2,2-bipyridine, H(2)bipt=2,5-bis[1,10]phenanthrolin[4,5-f]-(imidazol-2-yl)thiophene}, was prepared and the interaction between the complex and human telomeric DNA oligomers 5-G(3)(T(2)AG(3))(3)-3 (HTG21) has been investigated by UV-Vis, fluorescence and circular dichroism (CD) spectroscopy, fluorescence resonance energy transfer (FRET) melting assay, polymerase chain reaction (PCR) stop assay, fluorescent intercalator displacement (FID) titrations, Job plot and color reaction studies. The results indicate that the complex can well induce and stabilize the formation of antiparallel G-quadruplex of telomeric DNA in the presence or absence of metal cations, and the T-m value of the G-quadruplex DNA treated with the complex was obtained to be 12.8 degrees C even at levels of 50-fold molar of duplex DNA (calf-thymus DNA), suggesting that the complex exhibits higher G-quadruplex DNA selectivity over duplex DNA. The complex shows high interaction ability with G-quadruplex DNA at (1.17 +/- 0.12)x10(7)M(-1) binding affinity using a 2:1 [complex]/[quadruplex] binding mode ratio. A novel visual method has been developed here for making a distinction between G-quadruplex DNA and duplex DNA by our ruthenium complex binding hemin to form the hemin-G-quadruplex DNAzyme.

Synthesis of a Ruthenium(ii) Polypyridine Complex with 1,10-Phenanthrolineselenazole As Ligand and Investigation of Its G-quadruplex DNA-binding Properties

Ruthenium(II) polypyridyl complexes as G-quadruplex inducing and stabilizing ligands in telomeric DNA.

Targeting telomeric G-quadruplexes with the ruthenium(II) complexes [Ru(bpy)(2)(ptpn)](2+) and [Ru(phen)(2)(ptpn)](2+).

Polypyridyl Complexes of Ruthenium(Ii): Stabilization of G-Quadruplex Dna and Inhibition of Telomerase Activity

Synthesis, GC selective DNA binding and topoisomerase II inhibition activities of ruthenium(II) polypyridyl complex containing 11-aminopteridino[6,7-f][1,10]phenanthrolin-13(12H)-one.

[Ru(bpy)2(bppp)]2 + Binds Two Different Forms of the Human Telomeric G-quadruplex Structure

Ruthenium Polypyridyl Complex Bound to a Unimolecular Chair-Form G-Quadruplex

Trinuclear Ru(II) Polypyridyl Complexes As Human Telomeric Quadruplex DNA Stabilizers

Inducement and Stabilization of G-quadruplex DNA by a Thiophene-Containing Dinuclear Ruthenium(ii) Complex

Synthesis, Crystal Structure and DNA-binding Properties of Ruthenium(ii) Polypyridyl Complexes with Dicationic 2,2′-Dipyridyl Derivatives As Ligands

A Comparative Study of the Interaction of Two Structurally Analogous Ruthenium Complexes with Human Telomeric G-quadruplex DNA.

Synthesis, DNA-binding and Topoisomerase Inhibitory Activity of Ruthenium(ii) Polypyridyl Complexes

Synthesis, Characterization and DNA-binding Studies of Ruthenium(ii) Mixed-Ligand Complexes Containing Dipyrido[1,2,5]oxadiazolo[3,4-B]quinoxaline.

Novel ruthenium(II) polypyridyl complexes as G-quadruplex stabilisers and telomerase inhibitors.

Synthesis, DNA-binding and photocleavage studies of [Ru(phen)2(pbtp)]2+ and [Ru(bpy)2(pbtp)]2+ (phen = 1,10-phenanthroline; bpy = 2,2′-bipyridine; pbtp = 4,5,9,11,14-pentaaza-benzo[b]triphenylene)

Anticancer Activity of Novel Ruthenium Complex with 1,10-Phenanthrolineselenazole As Potent Telomeric G-Quadruplex Inhibitor

DNA interactions of a functionalized ruthenium(II) mixed-polypyridyl complex [Ru(bpy)2ppd]2+.

Stabilization of G-quadruplex DNA and Inhibition of Telomerase Activity Studies of Ruthenium(ii) Complexes.

Synthesis, DNA-binding and DNA-photocleavage properties of ruthenium(II) mixed-polypyridyl complex [Ru(tbz)2(dppz)]2+

Synthesis, DNA-binding and photocleavage studies of ruthenium(II) complex with 2-(3'-phenoxyphenyl)imidazo[4,5-f][1,10]phenanthroline.

Synthesis, structure and DNA-binding studies on the 2-(3-chlorophenyl)imidazo[4,5-f]1,10-phenanthroline-bis(2,2′-bipy ridine)-ruthenium(II) complex